Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Heparin Cofactor II Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5111426
Description
Immunogen sequence: EAQIADFSDP AFISKTNNHI MKLTKGLIKD ALENIDPATQ MMILNCIYFK GSWVNKFPVE MTHNHNFRLN E.
The product encoded by this gene is a serine proteinase inhibitor which rapidly inhibits thrombin in the presence of dermatan sulfate or heparin. The gene contains five exons and four introns. This protein shares homology with antithrombin III and other members of the alpha 1-antitrypsin superfamily. Mutations in this gene are associated with heparin cofactor II deficiency.
Specifications
| Heparin Cofactor II | |
| Polyclonal | |
| Unconjugated | |
| Serpind1 | |
| AA985900; AI303446; D22S673; HC2; Hcf2; HCII; HC-II; Heparin cofactor 2; heparin cofactor II; HLS2; leuserpin 2; leuserpin-2; LS2; Protease inhibitor leuserpin-2; rls2var1; serine (or cysteine) peptidase inhibitor, clade D, member 1; serine (or cysteine) proteinase inhibitor, clade D (heparin cofactor), member 1; serine (or cysteine) proteinase inhibitor, clade D, member 1; serpin D1; serpin family D member 1; serpin peptidase inhibitor, clade D (heparin cofactor), member 1; Serpind1; THPH10 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 3053 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Immunocytochemistry | |
| 0.10 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| P05546 | |
| Serpind1 | |
| Recombinant Protein corresonding to Human Heparin Cofactor II. Recombinant protein control fragment (Product #RP-101776). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction